Key features and details
- Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
- Rabbit monoclonal [EPR16550] to Glucose Transporter GLUT2 - BSA and Azide free
- Suitable for: WB
- Reacts with: Human
Product nameAnti-Glucose Transporter GLUT2 antibody [EPR16550] - BSA and Azide free
See all Glucose Transporter GLUT2 primary antibodies
DescriptionRabbit monoclonal [EPR16550] to Glucose Transporter GLUT2 - BSA and Azide free
Tested applicationsSuitable for: WBmore details
Species reactivityReacts with: Human
Recombinant fragment within Human Glucose Transporter GLUT2 aa 1-100. The exact sequence is proprietary.
Database link: P11168
- WB: Human fetal liver, fetal kidney and pancreas lysates; HepG2 cell lysate.
Ab236145 is the carrier-free version of ab192599. This format is designed for use in antibody labeling, including fluorochromes, metal isotopes, oligonucleotides, enzymes.
Our carrier-free formats are supplied in a buffer free of BSA, sodium azide and glycerol for higher conjugation efficiency.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with <1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
ab236145 is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm.
Maxpar® is a trademark of Fluidigm Canada Inc.
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free production
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
Storage instructionsShipped at 4°C. Store at +4°C. Do Not Freeze.
Storage bufferpH: 7.2
Concentration information loading...
PurityProtein A purified
- Pathways and Processes
- Metabolic signaling pathways
- Lipid and lipoprotein metabolism
- Lipid metabolism
Our Abpromise guarantee covers the use of ab236145 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||Use at an assay dependent concentration. Detects a band of approximately 57 kDa (predicted molecular weight: 57 kDa).|
FunctionFacilitative glucose transporter. This isoform likely mediates the bidirectional transfer of glucose across the plasma membrane of hepatocytes and is responsible for uptake of glucose by the beta cells; may comprise part of the glucose-sensing mechanism of the beta cell. May also participate with the Na(+)/glucose cotransporter in the transcellular transport of glucose in the small intestine and kidney.
Tissue specificityLiver, insulin-producing beta cell, small intestine and kidney.
Involvement in diseaseFanconi-Bickel syndrome
Sequence similaritiesBelongs to the major facilitator superfamily. Sugar transporter (TC 2.A.1.1) family. Glucose transporter subfamily.
modificationsN-glycosylated; required for stability and retention at the cell surface of pancreatic beta cells.
- Information by UniProt
- liver antibody
- Glucose Transporter 2 antibody
- Glucose Transporter GLUT2 antibody
All lanes : Anti-Glucose Transporter GLUT2 antibody [EPR16550] (ab192599) at 1/10000 dilution
Lane 1 : Human fetal liver lysate
Lane 2 : Human pancreas lysate
Lane 3 : Human fetal kidney lysate
Lane 4 : HepG2 cell lysate
Lysates/proteins at 20 µg per lane.
All lanes : Goat anti-rabbit IgG, (H+L), peroxidase conjugated at 1/1000 dilution
Developed using the ECL technique.
Predicted band size: 57 kDa
Observed band size: 57 kDa
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab192599).
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
ab236145 has not yet been referenced specifically in any publications.